Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age45-55
SponsorCairo University

About this trial

The purpose of this study is to investigate if there is any effect of the respiratory training on cardiopulmonary functions in patients with upper cross syndrome post-cardiac surgery.

Hypothesis:

Null hypothesis: There is no effect of the respiratory training on pulmonary functions in patients with upper cross syndrome post-cardiac surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.

Craniovertebral angle < 51°, but not less than 30°.

Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs.

VAS score between 3-7.

Disqualifiers

Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.

History of respiratory disease and clinical signs of severe cardiac events.

Neurological disorders which affect the diaphragm.

Patients whose BMI is less than 25, or greater than 30 kg/m2.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Respiratory Muscle Training by (The Breather)

    Other intervention

    Patients are instructed to inhale deeply and forcefully (at non fatigable resistance) for 2-3 seconds, slight pause, and then exhale forcefully for 2-3 seconds for 10 repetitions with 2 sets.

  • Traditional physical therapy program

    Other intervention

    Traditional physical therapy program in form of: (TENS / Low-intensity continuous ultrasonic / Infrared radiation application / Cervical Stabilization exercise )

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Respiratory training (study) group.Experimental treatment 2 interventions
Group B: Traditional (control) groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pulmonary functions:

Measurements of ventilatory function are recorded before and after receiving the treatment sessions (FEV1, FVC, FEV1/FVC, MVV). Assessing respiratory improvement. Unit of Measure: Liters (L)

Time frame
Baseline (assessment), and at 12 weeks post-intervention.
2

Six-Minute-Walk Test

Patients are asked to walk for 6 minutes along a flat corridor. Measured in meters, assessing exercise capacity and functional improvement. The SpO2 and heart rate are measured continuously during testing. Heart Rate (HR): Measured in beats per minute (BPM), evaluating cardiovascular response. SpO2 (Peripheral Oxygen Saturation): Assessing: Blood oxygen saturation levels to evaluate respiratory and cardiovascular efficiency. Unit of Measure: Percentage (%)

Time frame
Baseline (assessment), and at 12 weeks post-intervention.
3

VO2 max (Maximal Oxygen Consumption)

Assessing: Maximum oxygen uptake during high-intensity exercise to evaluate aerobic capacity and cardiopulmonary function. Estimated based on an equation which contains: weight is body weight (kg), 6MWD is distance walked in 6 min (m), age (years), BMI is calculated body mass index(kg/m2), height is body height (cm) and HR is heart rate at the end of the walking test. Unit of Measure: mL/kg/min

Time frame
Baseline (assessment), and at 12 weeks post-intervention.
4

Pittsburgh Sleep Quality Index.

Respondents are asked to indicate how frequently they have experienced certain sleep difficulties and rate them. Scores for each question range from 0 to 3, with higher scores indicating more acute sleep disturbances.

Time frame
Baseline (assessment), and at 12 weeks post-intervention.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.